drugset / Trial / NCT04047979
Systems Biology of Zoster Vaccine
Phase 2
Completed
38 enrolled
Emory University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to better understand how the immune system responds to the new herpes zoster (shingles) vaccine (Shingrix®). The study will be looking at certain markers in the blood after vaccination with Shingrix®.
Timeline
- Start
- 2019-11-14
- Primary completion
- 2023-04-03
- Completion
- 2023-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E | Vaccine | 0.5 ml | — |